Watching Protara Therapeutics, Opthea Ltd.; Shares Moving Higher As Traders Circulate Post From 'TipRanks' Suggesting "These 2 'Strong Buy' Penny Stocks Could Surge Over 400%, Says Oppenheimer"
Portfolio Pulse from Benzinga Newsdesk
Shares of Protara Therapeutics (TARA) and Opthea Ltd. (OPT) are experiencing an uptick as traders share a post from 'TipRanks' indicating that Oppenheimer analysts have rated these as 'Strong Buy' penny stocks, with a potential surge of over 400%.
May 09, 2024 | 2:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Opthea Ltd.'s shares are on the rise after a 'TipRanks' publication shared Oppenheimer's optimistic analysis, suggesting a potential 400% increase.
Given the high growth potential forecasted by Oppenheimer, investors are likely to be drawn to OPT, pushing its stock price higher in the short term.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Protara Therapeutics' stock is moving higher following a 'TipRanks' post that highlights an Oppenheimer analyst's 'Strong Buy' rating with over 400% surge potential.
The positive sentiment from a reputable financial analysis firm like Oppenheimer can significantly influence investor perception and drive up the stock price, especially for penny stocks like TARA.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90